Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (6): 509-513    DOI: 10.19485/j.cnki.issn2096-5087.2023.06.011
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
宝山区糖尿病高危人群筛查结果分析
丁承辉1, 吴萃1, 薛琨2, 励晓红2, 万金豹1, 陈秋艳1, 朱潇翔3
1.上海市宝山区疾病预防控制中心慢性病防制一科,上海 201901;
2.复旦大学,上海 200032;
3.上海市宝山区顾村镇菊泉新城社区卫生服务中心,上海 201907
Screening of diabetes among high-risk populations in Baoshan District
DING Chenghui1, WU Cui1, XUE Kun2, LI Xiaohong2, WAN Jinbao1, CHEN Qiuyan1, ZHU Xiaoxiang3
1. First Department of Chronic Disease Prevention and Control, Baoshan District Center for Disease Control and Prevention, Shanghai 201901, China;
2. Fudan University, Shanghai 200032, China;
3. Juquan New Town Community Health Service Center, Gucun Township, Baoshan District, Shanghai 201907, China
全文: PDF(767 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解上海市宝山区糖尿病高危人群糖尿病患病情况,为社区糖尿病防治工作提供依据。方法 采用多阶段分层整群随机抽样方法抽取宝山区≥35岁常住居民,采用《上海市社区居民糖尿病风险评估表》筛选糖尿病高危人群为调查对象,通过问卷调查收集人口学信息、疾病史和用药史等资料;测量身高、体重、腰围、臀围和血压;通过空腹血糖和口服葡萄糖耐量试验筛查糖尿病;采用多因素logistic回归模型分析糖尿病高危人群糖尿病患病的影响因素。结果 纳入糖尿病高危人群3 107人,其中男性1 165人,占37.50%;女性1 942人,占62.50%。年龄为(63.58±9.77)岁。检出糖尿病674例,检出率为21.69%。多因素logistic回归分析结果显示,男性(OR=1.689,95%CI:1.357~2.104)、年龄(40岁~,OR=4.833,95%CI:1.036~22.553;50岁~,OR=2.627,95%CI:1.432~4.819;60岁~,OR=1.551,95%CI:1.119~2.150;≥70岁,OR=1.579,95%CI:1.232~2.025)、中职/高中学历(OR=2.677,95%CI:1.636~4.380),超重/肥胖(OR=1.891,95%CI:1.447~2.472)、高血压(OR=1.306,95%CI:1.049~1.626)、血脂异常(OR=1.428,95%CI:1.114~1.831)、糖调节受损(OR=15.161,95%CI:11.827~19.434)和有2型糖尿病家族史(OR=2.092,95%CI:1.619~2.704)的高危人群糖尿病患病风险升高。结论 宝山区糖尿病高危人群糖尿病检出率为21.69%,性别、年龄、文化程度、超重/肥胖、高血压、血脂异常、糖调节受损和有2型糖尿病家族史是影响因素。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
丁承辉
吴萃
薛琨
励晓红
万金豹
陈秋艳
朱潇翔
关键词 糖尿病高危人群糖尿病危险因素    
AbstractObjective To investigate the prevalence of diabetes among individuals at high risk of diabetes in Baoshan District, Shanghai Municipality, so as to provide insights into community-based diabetes management. Methods Permanent residents at ages of 35 years and older were sampled from Baoshan District using a multistage stratified cluster sampling method, and residents at a high risk of diabetes were screened using the Form for Risk Assessment of Diabetes among Community Residents in Shanghai Municipality. Participants' demographics, disease history and history of medication were collected using questionnaire surveys, and height, body weight, waist circumference, hip circumference, and blood pressure were measured. Diabetes was screened using fasting blood glucose and glucose tolerance test. The factors affecting the development of diabetes were identified among high-risk residents for diabetes using a multivariable logistic regression model. Results A total of 3 107 residents at a high risk for diabetes were enrolled, including 1 165 men (37.50%) and 1 942 women (62.50%) with a mean age of (63.58±9.77) years. The prevalence of diabetes was 21.69% among the study subjects, and multivariable logistic regression analysis showed that men (OR=1.689, 95%CI: 1.357-2.104), age (40 years-, OR=4.833, 95%CI: 1.036-22.553; 50 years-, OR=2.627, 95%CI: 1.432-4.819; 60 years-, OR=1.551, 95%CI: 1.119-2.150; 70 years and older, OR=1.579, 95%CI: 1.232-2.025); high school/technical secondary school (OR=2.677, 95%CI: 1.636-4.380), overweight/obesity (OR=1.891, 95%CI: 1.447-2.472), hypertension (OR=1.306, 95%CI: 1.049-1.626), dyslipidemia (OR=1.428, 95%CI: 1.114-1.831), history of impaired glucose regulation (OR=15.161, 95%CI: 11.827-19.434) and family history of type 2 diabetes mellitus (OR=2.092, 95%CI: 1.619-2.704) caused an increased risk of diabetes among residents at a high risk diabetes. Conclusions The prevalence of diabetes was 21.69% among high-risk populations of diabetes in Baoshan District. Gender, age, educational level, overweight/obesity, hypertension, dyslipidemia, history of impaired glucose regulation and family history of type 2 diabetes mellitus are factors affecting the development of diabetes among high-risk populations.
Key wordshigh-risk population of diabetes    diabetes    risk factor
收稿日期: 2023-03-13      修回日期: 2023-04-30      出版日期: 2023-06-10
中图分类号:  R181  
基金资助:宝山区科技创新专项资金项目(19-E-11); 上海市加强公共卫生体系建设三年行动计划(GWV-7)
作者简介: 丁承辉,硕士,主管医师,主要从事慢性病预防与控制研究
通信作者: 朱潇翔,E-mail:18621601246@163.com   
引用本文:   
丁承辉, 吴萃, 薛琨, 励晓红, 万金豹, 陈秋艳, 朱潇翔. 宝山区糖尿病高危人群筛查结果分析[J]. 预防医学, 2023, 35(6): 509-513.
DING Chenghui, WU Cui, XUE Kun, LI Xiaohong, WAN Jinbao, CHEN Qiuyan, ZHU Xiaoxiang. Screening of diabetes among high-risk populations in Baoshan District. Preventive Medicine, 2023, 35(6): 509-513.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.06.011      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I6/509
[1] PORTA M,CURLETTO G,CIPULLO D,et al.Estimating the delay between on set and diagnosis of type 2 diabetes from the time course of retinopathy prevalence[J].Diabetes Care,2014,37(6):1668-1674.
[2] MAGLIANO D J,BOYKO E J,IDF Diabetes Atlas 10th edition scientific committee.IIDF Diabetes Atlas,10th edition[EB/OL].[2023-04-30].https://www.ncbi.nlm.nih.gov/books/NBK581934.
[3] 罗飞,胡劲松,黄霜,等.2018年长沙市糖尿病高危人群筛查结果分析[J].预防医学情报杂志,2021,37(11):1543-1549.
[4] BARRY E,ROBERTS S,OKE J,et al.Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes:systematic review and meta-analysis of screening tests and interventions[J/OL].BMJ,2017(4)[2023-04-30].https://doi.org/10.1136/bmj.i6538.
[5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中国糖尿病杂志,2014,22(8):2-42.
[6] 《中国老年型糖尿病防治临床指南》编写组.中国老年2型糖尿病防治临床指南(2022年版)[J].中国糖尿病杂志,2022,30(1):2-51.
[7] 梁森,韩冰,范雷,等.河南省35~74岁人群糖尿病患病率及相关因素分析[J].中华疾病控制杂志,2018,22(6):569-572,589.
[8] 闫世春,周雪,靳林,等.黑龙江省慢性病流行病学分析及防控策略研究[J].中国公共卫生管理,2019,35(4):518-521.
[9] 林乐韦华,欧倩滢,林璐,等.海南省城乡居民糖尿病患病率及合并其他慢性代谢性疾病调查[J].中国热带医学,2021,21(9):839-844.
[10] 麦勇强,丛守婧,张家泳,等.男性吸烟者吸烟行为与2型糖尿病关系[J].中国公共卫生,2018,34(8):1078-1082.
[11] 徐文超,覃玉,苏健,等.江苏省≥35岁社区居民饮酒与肥胖对糖尿病患病交互作用[J].中国公共卫生,2020,36(12):1776-1779.
[12] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[13] TABAK A G,HERDER C,RATHMANN W,et al.Prediabetes:a high-risk state for diabetes development[J].Lancet,2012,379(9833):2279-2290.
[1] 张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[2] 贾铭, 彭菊意, 刘星宇, 刘宇丹, 赵华. 心血管代谢性共病危险因素的Meta分析[J]. 预防医学, 2023, 35(9): 790-795.
[3] 张丹平, 徐玲妙. 糖尿病与血管性痴呆发病的关联、病理机制及防治策略研究[J]. 预防医学, 2023, 35(7): 582-586.
[4] 柏旭, 苏洁, 李凤, 徐倩, 沈源, 肖凌凤. 我国成人糖尿病视网膜病变影响因素的Meta分析[J]. 预防医学, 2023, 35(7): 595-601.
[5] 聂东梅, 李一鹏, 黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学, 2023, 35(7): 602-606.
[6] 张媛, 韩正风, 马艳. 老年人群肌少症危险因素的病例对照研究[J]. 预防医学, 2023, 35(6): 461-464.
[7] 沈放如, 杨可, 刘厚璞, 朱家豪, 李迎君. 新生儿出生体重与母亲2型糖尿病关联的双向孟德尔随机化研究[J]. 预防医学, 2023, 35(5): 384-387,409.
[8] 马奕竹, 赵效国, 朱启英, 马依拉·买买提, 张环美, 苑晓琳, 李莉. 孕期膳食模式与妊娠糖尿病的关联研究[J]. 预防医学, 2023, 35(4): 286-290.
[9] 黄文, 汤佳良, 陈康康, 黄敏钢, 陈奇峰. 绍兴市心血管疾病高危人群危险因素聚集分析[J]. 预防医学, 2023, 35(4): 298-302,330.
[10] 刘国志, 袁空军, 庄蔚, 周光清. 国内外城市社区2型糖尿病健康管理模式比较[J]. 预防医学, 2023, 35(3): 262-266.
[11] 谢睿, 胡菊莲, 喻喆. 妊娠糖尿病患者生活质量的影响因素研究[J]. 预防医学, 2023, 35(2): 162-165.
[12] 顾逸藜, 孙晓燕, 谢臻蔚. 女性糖尿病与压力性尿失禁研究进展[J]. 预防医学, 2023, 35(2): 130-133.
[13] 王晓薇, 许艳岚. 老年2型糖尿病患者认知衰弱风险预测研究[J]. 预防医学, 2023, 35(12): 1037-1042.
[14] 史美琦, 郑钜圣, 汪旭虹, 殷玉华, 胡文胜. 孕期膳食模式与妊娠糖尿病的关联分析[J]. 预防医学, 2023, 35(11): 921-925.
[15] 武亚星, 刘宏, 冯剑, 杨桂茂, 程雪兵, 徐茜, 孙晓东, 任艳峰. 2型糖尿病患者微血管并发症的影响因素分析[J]. 预防医学, 2023, 35(11): 926-930.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed